Opinion: Despite significant challenges, SAHPRA is on the right track

Opinion: Despite significant challenges, SAHPRA is on the right track

Recently the South African Health Products Regulatory Authority was criticised for not approving laboratory-based SARS-CoV-2 antibody tests. Spotlight Editor Marcus Low argues that despite the regulator’s capacity constraints, its flexible conservatism is something to be grateful for.

Read More